Sierra Summit Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,075
Closed -$223K 186
2025
Q2
$223K Sell
2,075
-84,985
-98% -$8.6M 0.04% 170
2025
Q1
$8.78M Sell
87,060
-31,290
-26% -$3.15M 1.9% 20
2024
Q4
$10.6M Buy
118,350
+8,135
+7% +$716K 2.12% 18
2024
Q3
$9.24M Sell
110,215
-36,815
-25% -$2.9M 2.12% 19
2024
Q2
$11.3M Buy
147,030
+9,018
+7% +$660K 2.81% 8
2024
Q1
$9.45M Sell
138,012
-1,033
-0.7% -$66.4K 2.57% 10
2023
Q4
$8.04M Buy
+139,045
New +$7.42M 2.34% 8

Other funds holding BSX

Sierra Summit Advisors's BSX Position: Q3 2025 in Review

Sierra Summit Advisors sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 2,075 shares — an estimated $223K sold.

Sierra Summit Advisors first reported a position in BSX in Q4 2023 and held it in 7 quarters. The position peaked at $11.3M in Q2 2024. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Sierra Summit Advisors reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Sierra Summit Advisors sold 2,075 Boston Scientific shares in Q3 2025, an estimated $223K.
  • Sierra Summit Advisors first reported a position in Boston Scientific in Q4 2023 and held it in 7 quarters.
  • Sierra Summit Advisors's Boston Scientific position peaked at $11.3M in Q2 2024.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Sierra Summit Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.